Martin A. Mattingly, Director at ONCOGENEX PHARMACEUTICALS, INC. (OGXI), bought 1,000 shares at $12.46 ($12K) on 2012-06-01, disclosed to the SEC on 2012-06-04.
Open-market purchase of $12k OGXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.